Zanamivir

Relenza 5 mg/dozi, prašak inhalata, dozirani

prašak inhalata, doziraniCroatiaNot marketedAuthorised 20 Aug 2021

In other countries

The same active substances on other registers, the same brand first.

RelenzaBrazil · Glaxosmithkline Brasil LtdaSame brand
RelenzaCanada · 5 MG / ACT · Powder · Glaxosmithkline INCSame brand
RELENZA 5 mg/dosis POLVO PARA INHALACIÓN (UNIDOSIS)Spain · 5 mg · polvo para inhalación · Glaxosmithkline S.A.Same brand
RelenzaItaly · Polvere per inalazione · Glaxosmithkline S.P.A.Same brand
Relenza 5 mg/dosis inhalatiepoeder, voorverdeeldNetherlands · Inhalatiepoeder, voorverdeeld · GlaxoSmithKline B.V.Same brand
Relenza RotadiskNew Zealand · Powder for inhalation 5 mgSame brand
Relenza®Serbia · 5mg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Zanamivir

Relenza 5 mg/dozi, prašak inhalata, dozirani

prašak inhalata, doziraniCroatiaNot marketedAuthorised 20 Aug 2021

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Relenza®Serbia · 5mg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. Beograd

Relenza 5MG Powder for InhalationSaudi Arabia · Glaxowellcome

RELENZA ROTADISK 5 mg/doseSingapore · 5 mg/dose · powder, metered · Glaxosmithkline Pte LTD

RelenzaUnited States · 5MG · powder · Glaxosmithkline

Dectova 10 MG/ML Solucion Para PerfusionSpain · 200 mg · solución para perfusión · Glaxosmithkline Trading Services Limited

DectovaEuropean Union · GlaxoSmithKline Trading Services Limited

DectovaItaly · Soluzione per infusione · Glaxosmithkline Trading Services Limited

Dectova 10 mg/ml, oplossing voor infusieNetherlands · Oplossing voor infusie · GlaxoSmithKline Trading Services Limited

Packs

Pack	Code	Status
20 doza praška u blisteru i 1 diskhaler inhalator, u kutiji	HR-H-442926310-01	nije stavljeno u promet

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Zanamivir
Dosage form: prašak inhalata, dozirani
Register: Croatia (HALMED)
Status: Not marketed
Status in the register: nije stavljeno u promet
Authorised: 20 Aug 2021
Registration: HR-H-442926310
Marketing authorisation holder: GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska
Manufacturer: Glaxo Wellcome Production, Evreux, Francuska
ATC code: J05AH01
Group: Anti-infectives for systemic use
Procedure: National, MRP or DCP
Supply: na recept; u ljekarni